EP 2841074 A1 20150304 - INTRAUTERINE APPLICATION OF 18-METHYL-15SS,16SS-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONE SYSTEMS, INTRAUTERINE SYSTEMS CONTAINING 18-METHYL-15SS,16SS-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONE, AS WELL AS THE USE THEREOF IN CONTRACEPTION AND GYNAECOLOGICAL THERAPY
Title (en)
INTRAUTERINE APPLICATION OF 18-METHYL-15SS,16SS-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONE SYSTEMS, INTRAUTERINE SYSTEMS CONTAINING 18-METHYL-15SS,16SS-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONE, AS WELL AS THE USE THEREOF IN CONTRACEPTION AND GYNAECOLOGICAL THERAPY
Title (de)
INTRAUTERINE ANWENDUNG VON 18-METHYL-15ß,16ß-METHYLEN-19-NOR-20-SPIROX-4-EN-3-ONEN, INTRAUTERINE SYSTEME ENTHALTEND 18-METHYL-15ß,16ß-METHYLEN-19-NOR-20-SPIROX-4-EN-3-ONE, SOWIE DEREN VERWENDUNG IN DER KONTRAZEPTION UND GYNÄKOLOGISCHEN THERAPIE
Title (fr)
UTILISATION INTRA-UTÉRINE DE 18-MÉTHYL-15 BÊTA, 16-BÊTA-MÉTHYLÈNE-19-NOR-20-SPIROX-4-EN-3-ONES, SYSTÈME INTRA-UTÉRIN CONTENANT DU 18-MÉTHYL-15 BÊTA, 16-BÊTA-MÉTHYLÈNE-19-NOR-20-SPIROX-4-EN-3-ONES, ET UTILISATION DESDITS COMPOSÉS POUR LA CONTRACEPTION ET LES TRAITEMENTS GYNÉCOLOGIQUES
Publication
Application
Priority
- DE 102012206652 A 20120423
- EP 2013058220 W 20130419
Abstract (en)
[origin: WO2013160213A1] The present invention describes the intrauterine application of 18-methyl-15ß,16ß-methylene-19-nor-20-spirox-4-en-3-one of the general formula (1) in contraception and gynaecological therapy, as well as an intrauterine system containing compounds of formula (1).
IPC 8 full level
A61F 6/14 (2006.01); A61K 31/58 (2006.01); A61P 15/00 (2006.01); A61P 15/18 (2006.01)
CPC (source: EP US)
A61K 9/0039 (2013.01 - EP US); A61K 31/58 (2013.01 - EP US); A61P 5/24 (2017.12 - EP); A61P 15/00 (2017.12 - EP); A61P 15/08 (2017.12 - EP); A61P 15/18 (2017.12 - EP)
Citation (search report)
See references of WO 2013160213A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2013160213 A1 20131031; AR 090799 A1 20141210; AU 2013254840 A1 20141106; BR 112014026193 A2 20170627; CA 2871003 A1 20131031; CL 2014002836 A1 20150313; CN 104254333 A 20141231; CO 7111255 A2 20141110; CR 20140490 A 20141117; CU 20140121 A7 20141226; DO P2014000241 A 20141231; EA 201491922 A1 20150430; EC SP14024250 A 20151231; EP 2841074 A1 20150304; HK 1205000 A1 20151211; IL 235095 A0 20141231; IN 7839DEN2014 A 20150424; JP 2015514791 A 20150521; KR 20150004807 A 20150113; MA 37444 A1 20161130; MX 2014012849 A 20150205; PE 20142438 A1 20150201; PH 12014502372 A1 20150126; SG 11201406582X A 20141127; TN 2014000444 A1 20160330; TW 201350122 A 20131216; US 2015065472 A1 20150305; UY 34758 A 20131129
DOCDB simple family (application)
EP 2013058220 W 20130419; AR P130101341 A 20130423; AU 2013254840 A 20130419; BR 112014026193 A 20130419; CA 2871003 A 20130419; CL 2014002836 A 20141021; CN 201380021453 A 20130419; CO 14235159 A 20141023; CR 20140490 A 20141023; CU 20140121 A 20141023; DO 2014000241 A 20141023; EA 201491922 A 20130419; EC PI201424250 A 20141024; EP 13717289 A 20130419; HK 15105985 A 20150624; IL 23509514 A 20141019; IN 7839DEN2014 A 20140919; JP 2015507482 A 20130419; KR 20147029292 A 20130419; MA 37444 A 20141021; MX 2014012849 A 20130419; PE 2014001786 A 20130419; PH 12014502372 A 20141022; SG 11201406582X A 20130419; TN 2014000444 A 20141022; TW 102112904 A 20130411; US 201314396736 A 20130419; UY 34758 A 20130423